Multi-site randomised controlled trial of fluoxetine in children and adolescents with autism. [ 2010 - 2013 ]

Research Grant

Researchers: Prof Dinah Reddihough (Principal investigator) ,  A/Pr John Wray ,  A/Pr Katherine Lee ,  A/Pr Michael Kohn ,  Dr Catherine Marraffa
View all 6 related researchers

Brief description Fluoxetine is a medication that is increasingly used in children with autism in an attempt to control repetitive behaviours, which substantially interfere with daily functioning and quality of life. However clinicians working in the field of autism and goverment regulatory bodies (such as the TGA) require evidence of the efficacy of fluoxetine for this indication. This study aims to determine this, thereby addressing an important gap in clinical knowledge.

Funding Amount $AUD 499,482.86

Funding Scheme NHMRC Project Grants

Notes Standard Project Grant